In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Boston Scientific acquires UK medical device company BTG in $4.2bn deal

Executive Summary

Boston Scientific Corp. agreed to acquire BTG plc (minimally invasive medical devices) for 840 pence per share ($10.76; 38% premium to the prior 10-day trading average) in cash or a total of £3.3bn ($4.2bn; enterprise value of $3.9bn).
Deal Industry
  • Medical Devices
    • Implantable Devices
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Contract
    • Full Acquisition
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register